Taiko Pharmaceutical Co.,Ltd. (4574.T)

JPY 322.0

(0.0%)

Annual Balance Sheets

(In JPY)
Breakdown 2022 2021 2020 2020 2019 2018
Total Assets 15.04 Billion 22.53 Billion 31.75 Billion 25.47 Billion 21.6 Billion 20.47 Billion
Total Current Assets 7.55 Billion 13.78 Billion 19.82 Billion 16.58 Billion 12.57 Billion 11.76 Billion
Cash And Short Term Investments 3.5 Billion 6.09 Billion 4.94 Billion 9.9 Billion 7.22 Billion 6.54 Billion
Cash and Cash Equivalents 3.1 Billion 5.79 Billion 4.94 Billion 9.9 Billion 7.22 Billion 6.54 Billion
Short Term Investments 400 Million 302 Million - - -277.41 Million -
Net Receivables 1.79 Billion 4.05 Billion 7.91 Billion 4.41 Billion 3.64 Billion 3.58 Billion
Inventory 1.95 Billion 3.2 Billion 6.4 Billion 2.02 Billion 1.54 Billion 1.52 Billion
Other Current Assets 301 Million 424 Million 549.92 Million 233.44 Million 160.63 Million 106.7 Million
Total Non-Current Assets 7.48 Billion 8.75 Billion 11.93 Billion 8.88 Billion 9.02 Billion 8.7 Billion
Net PPE 6.39 Billion 7.11 Billion 9.44 Billion 7.1 Billion 7.37 Billion 7.89 Billion
Good Will And Intangible Assets 222 Million 299 Million 319.12 Million 220.41 Million 237.63 Million 92.21 Million
Good Will - - - - 630 Thousand -
Intangible Assets - - - - 237 Million -
Long-Term Investments 133 Million 709 Million 1.23 Billion 735.25 Million 1.01 Billion 332.16 Million
Tax Assets 2 Million 302 Million 605.14 Million 547.44 Million 401.27 Million 107.1 Million
Other Non Current Assets 733 Million 327 Million 333.38 Million 278.23 Million -104 Thousand 281.91 Million
Other Assets 3 Million 2 Million 2000.00 1000.00 3000.00 -1000.00
Total Liabilities 7 Billion 9.73 Billion 8.97 Billion 6.09 Billion 4.11 Billion 4.05 Billion
Total Current Liabilities 2.79 Billion 4.32 Billion 7.48 Billion 4.79 Billion 2.82 Billion 2.81 Billion
Account Payables 274 Million 309 Million 2.92 Billion 1 Billion 514 Million 424.48 Million
Tax Payables 17 Million 12 Million 1.11 Billion 937.35 Million 440.79 Million 332.52 Million
Short Term Debt 1.06 Billion 959 Million 31.07 Million 25.75 Million 16.2 Million 13.75 Million
Deferred Revenue 1.2 Billion 2.13 Billion 3.81 Billion 3.04 Billion 1.92 Billion 2.13 Billion
Other Current Liabilities 250 Million 922 Million 713.09 Million 721.01 Million 366.17 Million 238.38 Million
Total Non Current Liabilities 4.21 Billion 5.41 Billion 1.48 Billion 1.3 Billion 1.28 Billion 1.23 Billion
Long-Term Debt 2.74 Billion 3.81 Billion 63.81 Million 52.24 Million 39.2 Million 15.35 Million
Deferred Revenue Non Current 1.2 Billion 1.35 Billion - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 136 Million 138 Million 1.42 Billion 1.25 Billion 1.24 Billion 1.22 Billion
Other Liabilities - - - - - -
Total Equity 8.04 Billion 12.8 Billion 22.78 Billion 19.37 Billion 17.48 Billion -
Stock Holders Equity 8.04 Billion 12.8 Billion 22.78 Billion 19.37 Billion 17.48 Billion 16.41 Billion
Common Stock 1.2 Billion 1.2 Billion 1.14 Billion 1.03 Billion 776.31 Million -
Retained Earnings 5.23 Billion 10.13 Billion 20.5 Billion 17.53 Billion 15.57 Billion 14.66 Billion
Accumulated other comprehensive income - - - - - -
Common Stock Equity 8.04 Billion 12.8 Billion 22.78 Billion 19.37 Billion 17.48 Billion 16.41 Billion
Capital Lease Obligation 50 Million 90 Million 94.89 Million 78 Million 55.41 Million 29.1 Million
Total Investments 533 Million 1.01 Billion 1.23 Billion 735.25 Million 740.58 Million 332.16 Million
Total Debt 3.8 Billion 4.77 Billion 94.89 Million 78 Million 55.41 Million 29.1 Million
Net Debt 704 Million -1.02 Billion -4.84 Billion -9.82 Billion -7.16 Billion -6.51 Billion

Balance Sheet Charts